Kenneth S. Boger

2009

In 2009, Kenneth S. Boger earned a total compensation of $3.2M as Senior Vice President and Chief Legal Officer at Vertex Pharmaceuticals, a 65% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$324,613
Option Awards$2,056,972
Salary$426,214
Stock Awards$340,968
Other$12,316
Total$3,161,083

Boger received $2.1M in option awards, accounting for 65% of the total pay in 2009.

Boger also received $324.6K in non-equity incentive plan, $426.2K in salary, $341K in stock awards and $12.3K in other compensation.

Rankings

In 2009, Kenneth S. Boger's compensation ranked 1,424th out of 9,885 executives tracked by ExecPay. In other words, Boger earned more than 85.6% of executives.

ClassificationRankingPercentile
All
1,424
out of 9,885
86th
Division
Manufacturing
508
out of 3,690
86th
Major group
Chemicals And Allied Products
103
out of 871
88th
Industry group
Drugs
68
out of 643
89th
Industry
Pharmaceutical Preparations
55
out of 446
88th
Source: SEC filing on April 8, 2011.

Boger's colleagues

We found six more compensation records of executives who worked with Kenneth S. Boger at Vertex Pharmaceuticals in 2009.

2009

Matthew Emmens

Vertex Pharmaceuticals

Chief Executive Officer

2009

Nancy Wysenski

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

2009

Joshua Boger

Vertex Pharmaceuticals

Chief Executive Officer

2009

Peter Mueller

Vertex Pharmaceuticals

Chief Scientific Officer

2009

Ian Smith

Vertex Pharmaceuticals

Chief Financial Officer

2009

Amit Sachdev

Vertex Pharmaceuticals

Senior Vice President, Corporate Affairs and Public Policy, and Commercial Business Lead, Canada

In-depth

You may also like